Volume 25, Issue 6 pp. 739-745
Kidney disease and OSA

Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study

Oreste Marrone

Corresponding Author

Oreste Marrone

CNR, Institute of Biomedicine and Molecular Immunology, Palermo, Italy

Correspondence

Dr Oreste Marrone, Consiglio Nazionale delle Ricerche, Istituto di Biomedicina e Immunologia Molecolare, Via Ugo La Malfa 153, 90146 Palermo, Italy.

Tel.: (+39)0916809136;

fax: (+39)0916809127;

e-mail: [email protected]

Search for more papers by this author
Salvatore Battaglia

Salvatore Battaglia

DiBiMIS, University of Palermo, Palermo, Italy

Search for more papers by this author
Paschalis Steiropoulos

Paschalis Steiropoulos

Sleep Unit, Department of Pneumology, Democritus University of Thrace, Alexandroupolis, Greece

Search for more papers by this author
Ozen K. Basoglu

Ozen K. Basoglu

Department of Chest Diseases, Ege University School of Medicine, Izmir, Turkey

Search for more papers by this author
John A. Kvamme

John A. Kvamme

ENT Department, Førde Central Hospital, Førde, Norway

Search for more papers by this author
Silke Ryan

Silke Ryan

School of Medicine and Medical Science, University College Dublin, Dublin, Ireland

Pulmonary and Sleep Disorders Unit, St Vincent's University Hospital, Dublin, Ireland

Search for more papers by this author
Jean-Louis Pepin

Jean-Louis Pepin

INSERM, Laboratoire HP2, and CHU de Grenoble, Pôle Thorax et Vaisseaux, Université Grenoble Alpes, Grenoble, France

Search for more papers by this author
Johan Verbraecken

Johan Verbraecken

Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Edegem-Antwerp, Belgium

Search for more papers by this author
Ludger Grote

Ludger Grote

Sleep Medicine, Sahlgrenska University Hospital and Sahlgrenska Academy, Gothenburg, Sweden

Search for more papers by this author
Jan Hedner

Jan Hedner

Sleep Medicine, Sahlgrenska University Hospital and Sahlgrenska Academy, Gothenburg, Sweden

Search for more papers by this author
Maria R. Bonsignore

Maria R. Bonsignore

CNR, Institute of Biomedicine and Molecular Immunology, Palermo, Italy

DiBiMIS, University of Palermo, Palermo, Italy

Search for more papers by this author
on behalf of the ESADA study group
First published: 18 May 2016
Citations: 59

Summary

The cross-sectional relationship of obstructive sleep apnea with moderate to severe chronic kidney disease, defined as an estimated glomerular filtration rate <60 mL min−1∙1.73 m−2, was investigated in a large cohort of patients with suspected obstructive sleep apnea studied by nocturnal polysomnography or cardiorespiratory polygraphy. Data were obtained from the European Sleep Apnea Database, where information from unselected adult patients with suspected obstructive sleep apnea afferent to 26 European sleep centres had been prospectively collected. Both the Modification of Diet in Renal Disease and the Chronic Kidney Disease-Epidemiology Collaboration equations were used for the assessment of estimated glomerular filtration rate. The analysed sample included 7700 subjects, 71% male, aged 51.9 ± 12.5 years. Severe obstructive sleep apnea (apnea–hypopnea index ≥30) was found in 34% of subjects. The lowest nocturnal oxygen saturation was 81 ± 10.2%. Chronic kidney disease prevalence in the whole sample was 8.7% or 6.1%, according to the Modification of Diet in Renal Disease or the Chronic Kidney Disease-Epidemiology Collaboration equations, respectively. Subjects with lower estimated glomerular filtration rate were older, more obese, more often female, had worse obstructive sleep apnea and more co-morbidities (P < 0.001, each). With both equations, independent predictors of estimated glomerular filtration rate <60 were: chronic heart failure; female gender; systemic hypertension; older age; higher body mass index; and worse lowest nocturnal oxygen saturation. It was concluded that in obstructive sleep apnea, chronic kidney disease is largely predicted by co-morbidities and anthropometric characteristics. In addition, severe nocturnal hypoxaemia, even for only a small part of the night, may play an important role as a risk factor for kidney dysfunction.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.